monoclonal antibody 8H9
a murine IgG(1) monoclonal antibody that recognizes cell surface tumor antigen broadly distributed on neuroectodermal, epithelial, and mesenchymal tumors, including rhabdomyosarcoma; may have a potential clinical role in radioimmunotherapy
Also Known As:
8H9 MAb
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
for this Bio-Agent,
Comments
Bio-Agent Context: Research Results
Experts
| 1. | Souweidane, Mark M: 2 articles (04/2010 - 12/2008) |
| 2. | Luther, Neal: 2 articles (04/2010 - 12/2008) |
| 3. | Gutin, Philip H: 2 articles (04/2010 - 12/2008) |
| 4. | Edgar, Mark A: 2 articles (04/2010 - 12/2008) |
| 5. | Souliopoulos, Eleni P: 1 article (04/2010) |
| 6. | Pastan, Ira: 1 article (04/2010) |
| 7. | Karempelas, Ioannis: 1 article (04/2010) |
| 8. | Karampelas, Ioannis: 1 article (04/2010) |
| 9. | Guo, Hong-Fen: 1 article (04/2010) |
| 10. | Cheung, Nai-Kong: 1 article (04/2010) |
Related Diseases
| 1. | Glioma (Gliomas)
12/01/2008
- "Intraparenchymal and intratumoral interstitial infusion of anti-glioma monoclonal antibody 8H9."
04/01/2010 - "Monoclonal antibody 8H9 is specific for membrane protein B7H3 and is reactive with most human high-grade gliomas. " Order ALL the reference details at left... |
| 2. | Rhabdomyosarcoma
10/01/2005
- "Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9."
Order ALL the reference details at left... |
| 3. | Neuroblastoma
05/15/2001
- "Monoclonal antibody 8H9 is a murine IgG1 hybridoma derived from the fusion of mouse myeloma SP2/0 cells and splenic lymphocytes from BALB/c mice immunized with human neuroblastoma. "
Order ALL the reference details at left... |
| 4. | Neoplasms (Cancer)
05/15/2001
- "Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors."
Order ALL the reference details at left... |
Related Drugs and Biologics
| 1. | Membrane Proteins (Integral Membrane Proteins)
|
| 2. | Immunoglobulin G (IgG)
|
| 3. | Surface Antigens (Surface Antigen)
|
TREATMENT OPTIONS
for Glioma,
Ranking and Evidence
for Glioma,
Ranking and Evidence
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
Analytic charts allow you and your physicians to see at a glance the
treatment options—including new, promising, off-label and experimental.
- Free Updates for 1 Year
- All 932 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Evidence References
- Sample PDF Report on Psoriasis >>
| Price: | $24.95 USD
& Delivery via
PDF download
updates for 1 year |
Research Interface PRO
- Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
- Enable Experts: Quickly identify key researchers and their publications
- Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
- Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
- Research Network: Explore drug and disease relationships visually
- Enable Mobile Interface: Access from your cellphone, iPhone or PDA
| Price: | $490.00 USD
access via web interface 1 year subscription |